InMode Ltd. INMD shares are up during Friday’s premarket session after the company announced a new share repurchase program.
InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...
Wall Street expects a year-over-year increase in earnings on higher revenues when InMode (INMD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...
On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash.
InMode Ltd. boasts superior fundamentals, yet trades at undervalued market multiples due to its unique risk profile. The company is a leader in the global aesthetics market with proprietary RF-based ...
YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to ...
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...
Image source: The Motley Fool. Gross margins decline — Yair Malca stated, "GAAP and non-GAAP gross margins in Q3 were 78%, down from 82% reported in Q3 2024," citing the anticipated impact of tariffs ...
YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results